The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNahl Group Regulatory News (NAH)

Share Price Information for Nahl Group (NAH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 66.00
Bid: 65.00
Ask: 69.00
Change: 0.00 (0.00%)
Spread: 4.00 (6.154%)
Open: 66.00
High: 66.00
Low: 66.00
Prev. Close: 67.00
NAH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Awards under Group Share Option Plan

2 May 2023 12:57

RNS Number : 1424Y
NAHL Group PLC
02 May 2023
 

2 May 2023

NAHL Group PLC

("NAHL" or the "Group")

Grant of Awards under Group Share Option Plan

 

NAHL (AIM: NAH), a leading marketing and services business focused on the UK consumer legal market, announces that on 28 April 2023, it awarded 1,146,000 options over new ordinary shares of 0.25 pence each in the Group ("Ordinary Shares") to certain employees and directors of the Group under the NAHL Group Share Option Plan. This included awards to James Saralis and Chris Higham as set out below:

 

Name

Title

Number of options granted

Exercise price

James Saralis

Chief Executive Officer

310,000

£0.0025

Christopher Higham

Chief Financial Officer

210,000

£0.0025

 

These options have been granted in line with the Group's Remuneration Policy and are in the form of nominal cost share options each exercisable at the nominal value of an Ordinary Share of 0.25p ("Restricted Share Awards") and vest after three years, subject to continued employment with the Group. In addition, although no performance related vesting criteria will apply to the Restricted Share Awards, the Remuneration Committee of the Board has discretion to amend the number of Restricted Shares Awards to be vested should the amount vesting not reflect the Remuneration Committee's assessment of overall business performance.

 

Following the grant of these options, James Saralis is now interested in a total of 999,313 share options in the Group and Chris Higham is now interested in a total of 511,999 share options in the Group.

 

Following this grant there are a total of 3,984,282 share options granted over unissued Ordinary Shares granted to directors and employees, representing 8.60% of the Group's current ordinary share capital of 46,325,222 Ordinary Shares.

 

The below notifications made in accordance with the requirements of the UK Market Abuse Regulation provide further detail:

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Mr James Saralis

2.

Reason for the notification

a)

Position / status

Chief Executive Officer (Director and PDMR)

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer

a)

Name

NAHL Group plc

b)

LEI

213800FQN7XBX1S6U981

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Options over ordinary shares of 0.25 pence each

b)

Identification code

GB00BM7S2W63

 

c)

Nature of the transaction

Grant of options

d)

Price(s) and volume(s)

 

Price

Volume

£0.0025

310,000

e)

Aggregated information

- Volume

- Price

As above

f)

Date of the transaction

28 April 2023

g)

Place of the transaction

Outside of a trading venue

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Mr Christopher Higham

2.

Reason for the notification

a)

Position / status

Chief Financial Officer (PDMR)

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer

a)

Name

NAHL Group plc

b)

LEI

213800FQN7XBX1S6U981

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Options over ordinary shares of 0.25 pence each

b)

Identification code

GB00BM7S2W63

 

c)

Nature of the transaction

Grant of options

d)

Price(s) and volume(s)

 

Price

Volume

£0.0025

210,000

e)

Aggregated information

- Volume

- Price

As above

f)

Date of the transaction

28 April 2023

g)

Place of the transaction

Outside of a trading venue

 

For further information:

 

NAHL Group PLC

James Saralis (CEO)

Chris Higham (CFO)

 

 

via FTI Consulting

Tel: +44 (0) 20 3727 1000

Allenby Capital (AIM Nominated Nomad & Broker)

Jeremy Porter/Vivek Bhardwaj (Corporate Finance)

Amrit Nahal/Stefano Aquilino (Sales & Corporate Broking)

 

 

Tel: +44 (0) 20 3328 5656

FTI Consulting (Financial PR)

Alex Beagley

Sam Macpherson

Amy Goldup

 

Tel: +44 (0) 20 3727 1000

NAHL@fticonsulting.com

 

Notes to Editors

 

NAHL Group plc (AIM: NAH) is a leader in the Consumer Legal Services market. The Group provides services and products to individuals and businesses in the through its two divisions:

 

· Consumer Legal Services provides outsourced marketing services to law firms through National Accident Helpline and claims processing services to individuals through Your Law, Law Together and National Accident Law. In addition, it also provides property searches through Searches UK.

· Critical Care provides a range of specialist services in the catastrophic and serious injury market to both claimants and defendants through Bush & Co.

 

More information is available at www.nahlgroupplc.co.uk, www.national-accident-helpline.co.uk, www.national-accident-law.co.uk and www.bushco.co.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAFSAESSDEFA
Date   Source Headline
24th Apr 20245:06 pmRNSIssue of Equity from Share Options and TVR
23rd Apr 20247:00 amRNSNotice of Results and Investor Presentation
5th Apr 20241:51 pmRNSHolding(s) in Company
5th Apr 202412:19 pmRNSResponse to speculation
8th Mar 20247:00 amRNSRenewal of Banking Facilities
24th Jan 20247:00 amRNSYear End Trading Update
30th Oct 20237:00 amRNSGrant of options under SAYE Scheme
19th Oct 20236:07 pmRNSHolding(s) in Company
26th Sep 20237:00 amRNSInterim Results
13th Sep 20237:00 amRNSNotice of Results and Investor Presentation
31st Jul 20235:00 pmRNSTotal Voting Rights
26th Jul 20237:00 amRNSHalf Year Trading Update
2nd Jun 20235:24 pmRNSDirector/PDMR Shareholding
31st May 20235:00 pmRNSTotal Voting Rights
31st May 20233:50 pmRNSIssue of Equity and Total voting rights
25th May 20231:50 pmRNSHolding(s) in Company
25th May 20231:19 pmRNSResult of AGM
25th May 20237:00 amRNSAGM Statement
19th May 20233:16 pmRNSIssue of Equity from Exercise of Share Options
18th May 20237:49 amRNSHolding(s) in Company
2nd May 202312:57 pmRNSGrant of Awards under Group Share Option Plan
28th Apr 20238:28 amRNSAnnual Report & Accounts and Notice of AGM
25th Apr 20237:00 amRNSSale of Homeward Legal
24th Apr 20232:43 pmRNSHolding(s) in Company
24th Mar 20234:59 pmRNSFinal Results – replacement
22nd Mar 20237:00 amRNSFinal Results
16th Mar 20237:00 amRNSNotice of Investor Presentation
24th Jan 20237:00 amRNSYear End Trading Update and Notice of Results
5th Dec 20222:42 pmRNSHolding(s) in Company
27th Sep 20227:00 amRNSInterim Results
22nd Sep 20227:00 amRNSNotice of Results and Investor Presentation
15th Sep 20227:00 amRNSDirectorate changes
2nd Aug 20221:15 pmRNSHolding(s) in Company
1st Aug 20227:00 amRNSHalf Year Trading Update
14th Jul 20221:58 pmRNSHolding(s) in Company
7th Jul 20224:44 pmRNSHoldings in Company
15th Jun 202212:13 pmRNSResult of AGM
15th Jun 20227:00 amRNSAGM Statement
10th May 20227:00 amRNSAnnual Report & Accounts and Notice of AGM
28th Apr 20227:00 amRNSGrant of Awards under Group Share Option Plan
29th Mar 20227:00 amRNSFinal Results
15th Mar 20227:00 amRNSNotice of Investor Presentation
11th Feb 20227:00 amRNSChange of Nominated Adviser and Broker
19th Jan 20227:00 amRNSTrading Update and Revised Banking Facility
5th Jan 20225:02 pmRNSHolding(s) in Company
9th Dec 20217:00 amRNSIssue of Equity from Exercise of Share Options
14th Oct 20214:41 pmRNSSecond Price Monitoring Extn
14th Oct 20214:36 pmRNSPrice Monitoring Extension
28th Sep 20217:00 amRNSInterim Results
23rd Sep 20217:00 amRNSNotice of Investor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.